12.98
-3.71%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Yixintang Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 002727.SZ. It has been listed since 2 July 2014. In the fiscal year to 31 December 2025, it reported revenue of CN¥17.34bn and net income of CN¥263.4m. At that date it held total assets of CN¥15.61bn and shareholders' equity of CN¥7.30bn.
Yixintang Pharmaceutical Group Co., Ltd. engages in the pharmaceutical retail chain and pharmaceutical wholesale business. The company is headquartered in Kunming, Yunnan. The company went IPO on 2014-07-02. The Company’s main products include traditional Chinese medicines, western medicines, medical equipment, birth control products and disinfection products, among others. The firm distributes its products through regular chain drugstores. The firm mainly operates its business in domestic market, with southwest area of China as its main market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 2 Jul 2014
- Employees
- 33,176
- Website
- yixintanggroup.com ↗
Leadership
Pay as last reported
- Mr. Hongxian RuanChairman of the Board, President, since 2009CN¥1.0m
- Mr. Yong ZhangExecutive President, Director, since 2019CN¥1.0m
- Mr. Donglei XiaoChief Financial Officer, Finance DirectorCN¥420,000
- Mr. Zhenghong LiVice President, Secretary of the BoardCN¥500,000
- Mr. Guowei RuanVice President, Director, since 2019CN¥860,000
- Ms. Aixiang RuanVice President
- Ms. Chunli GuoDirectorCN¥860,000
- Ms. Qiong LiuDirector, since 2010CN¥100,800
- Mr. Keyi XuDirector
- Mr. Xudong ChenIndependent DirectorCN¥120,000
- Mr. Xiaohai LongIndependent DirectorCN¥120,000
- Mr. Xianming YangIndependent DirectorCN¥120,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 48
- Environment
- 56
- Social
- 12
- Governance
- 77
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Yixintang Pharmaceutical employs 33,176 full-time employees in Kunming, China.
- The company operates 33,176 retail stores across China's southwest region.
- Yixintang's main products include traditional Chinese medicines and western medicines.
Weaknesses
- The company's business is limited to the domestic market in China.
- Yixintang's main market is the southwest region of China, which is geographically constrained.
- The company's retail chain business is concentrated in the southwest area of China.
Opportunities
- Yixintang could expand its pharmaceutical wholesale business into new domestic markets.
- The company may grow its retail chain by entering new regions in China.
- Yixintang can leverage its product range to increase market share in China.
Threats
- The company faces competition from other pharmaceutical retailers in China.
- Yixintang's reliance on the southwest region could be a vulnerability.
- The domestic market in China may face regulatory changes affecting pharmaceuticals.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.